Enzyme activity of circulating CD73 in human serum

Area of Science:

• Biochemistry
• Immunology
• Oncology

Background:

• CD73 is an ectonucleotidase that converts 5'-adenosine monophosphate (AMP) to adenosine extracellularly.
• Extracellular adenosine is a key regulator in physiological and pathological conditions, including cancer.
• Elevated CD73 expression in cancer leads to increased adenosine, which suppresses T-cell responses and promotes tumor progression.

Purpose of the Study:

• To investigate the role of CD73 in cancer progression and immunotherapy resistance.
• To explore the potential of targeting CD73 or adenosine receptors as a therapeutic strategy.
• To develop and describe a method for measuring CD73 activity in biological fluids for patient stratification.

Main Methods:

• Enzyme activity assay to measure AMPase activity of CD73.
• Application of the assay to peripheral blood samples.
• Potential adaptation for other biological fluids.

Main Results:

• The study describes a simple and fast method for evaluating CD73 AMPase activity.
• This method can be applied to peripheral blood and potentially other biological fluids.
• The findings support the measurement of CD73 levels as a biomarker.

Conclusions:

• Increased CD73-generated adenosine impairs cancer immunotherapy efficacy.
• Inhibitors of CD73 and adenosine receptor antagonists are promising therapeutic agents.
• Measuring CD73 activity in serum may help select patients for adenosine-targeting therapies and predict immunotherapy response.